Archive for the 'Asbestos & Mesothelioma Studies' Category

Asbestos & Mesothelioma Studies news feed.

Quality of Life After Pleurectomy/Decortication vs. Extra Pleural Pneumonectomy

On the rare instance that mesothelioma is diagnosed in the early stages of the disease, patients have the option for surgery.  There are several surgical procedures used to treat mesothelioma. Some mesothelioma surgeries aim to provide a curative effect, while others are performed for palliative purposes. Pleurectomy/decortication (P/D) and extra pleural pneumonectomy (EPP) are two

more

Phase 1 Clinical Trial For Those With Peritoneal Mesothelioma Underway

Mesothelioma is a rare cancer affecting only about 3,000 Americans each year. Most of those diagnosed are diagnosed with pleural mesothelioma, but a small number (approx. 500 per year) are diagnosed with peritoneal mesothelioma, which is mesothelioma in the abdominal lining. With so few diagnosed with peritoneal mesothelioma, studying and evaluating the illness has been

more

Decade Long Study Reveals Potential for Early Detection in Mesothelioma

For many patients who are suffering from malignant mesothelioma, their diagnosis came quickly after experiencing symptoms. In many cases, this is because symptoms of mesothelioma typically do not appear until the cancer has fully developed and it’s in the later stages. For those suffering from pleural mesothelioma – the most common type – 90 percent

more

Researchers Theorize Drug from the 1800s Could Improve Radiation Treatments in Mesothelioma Patients

Radiation therapy for those suffering from mesothelioma is not typically the first line of treatment because of its overall effectiveness. High-energy x-rays, gamma rays, and neutrons that make up radiation treatment aim to shrink tumors and ultimately kill cancer cells, but since mesothelioma tumors often have an irregular shape, it can be difficult to target

more

Phase III Clinical Trial for Nintedanib Discontinued After Yielding Negative Results

Disappointing results from the LUME-Phase III clinical trial regarding nintedanib is a setback for scientists and researchers who were hopeful they were on the brink of finding a new, first line treatment for those suffering from mesothelioma. Results from the Phase II clinical trial – published earlier this year – showed promise for the triple

more

Survival Improves in Mesothelioma Patients who Received an Electricity-Based Treatment

The success of a recent Phase II clinical trial in malignant pleural mesothelioma has scientists and researchers excited about the possibility of adding a new treatment that will not only improve survival, but also improve quality of life of the cancer patient. Tumor Treating Fields, which is a therapy that uses alternating electric fields to

more

Sarcopenia in Relation to Overall Survival in Peritoneal Mesothelioma

Peritoneal mesothelioma only affects about 500 people each year, but its aggressive nature makes it hard to treat successfully and many who are diagnosed will on average survive only 6 to 12 months. Peritoneal mesothelioma is a cancer affecting the abdominal lining, or peritoneum, which is why it is sometimes referred to as abdominal mesothelioma. Asbestos

more

Empathetic Nurses Have Positive Impact on Cellular Activity in Pleural Mesothelioma Patients

A mesothelioma diagnosis and the treatment involved take a dramatic toll on the body and the mind, and with no known cure for mesothelioma, it is understandable that many feel loss of hope and despair. However, a recent study showed that having good mental health can improve treatment outcome, and it is directly related to

more

Giant Steps Back in the Fight to Ban Asbestos In the United States

Under the Obama Administration, The Toxic Substances Control Act (TSCA) was updated to give the Environmental Protection Agency (EPA) more authority to ban asbestos completely in the United States. The carcinogen was originally banned in 1989, but by 1991 the ruling was over-turned. Anti-asbestos advocates have been fighting ever since to ban all uses of

more

New Surgical Technique Illuminates Previously Undetected Mesothelioma Tumors

In addition to chemotherapy, radiation therapy, and immunotherapy, those suffering from mesothelioma also have the option for surgery (if they are physically able). Surgery is one of the better options for mesothelioma patients because it can remove most if not all the cancer; however, often times since the cancer is generally diagnosed in the later

more

Metal-based Compound May Reduce Tumor Size in Pleural, Peritoneal Mesothelioma

Mesothelial cells are found in the lining of major organs such as the chest or the abdomen. When asbestos fibers are inhaled or ingested, they slice through the soft tissue and become embedded in the lining of these organs. These fibers cause genetic mutations in the mesothelial cells which then cause the cells to reproduce

more

Potential Breakthrough in Immunotherapy after Nivolumab Study Results

Immunotherapy treatments have once again made headlines, revolutionizing modern medicine and the way we have come to understand cancer treatment. The latest study results published in the American Journal of Case Reports, focuses on Opdivo (nivolumab), a type of check point inhibitor designed to stop immune cells from attacking the healthy cells that are needed

more

Pneumothorax Helps Improve CT Scans, Early Detection for Mesothelioma Patients

Diagnosing mesothelioma in the early stages of the disease has proven to be a difficult task, and to better improve chances of survival from this aggressive cancer, the  cancer needs to be found and treated quickly. Typical first steps in diagnosing mesothelioma are imaging techniques such as an x-ray, CT (CAT) scan, or an MRI.

more

Nintedanib May Surpass Bevacizumab as a More Effective Chemotherapy Treatment for Mesothelioma

In 2016, scientists and researchers were excited to begin Phase II of the clinical trial involving treating patients with malignant pleural mesothelioma with Nintedanib, a triple angiokinase inhibitor designed to hinder protein kinases in cancer cells and stop cancer cells from growing their own blood vessels. The LUME-Meso Phase II trial yielded promising results –

more

EPA Proposes New Rules For Asbestos; Anti-Asbestos Advocates Concerned

In June 2016, former President Obama signed the Frank R. Lautenberg Chemical Safety for the 21st Century Act as an amendment to the Toxic Substances Control Act (TSCA), and since then, the Environmental Protection Agency (EPA) has been moving forward in naming asbestos – as well as nine other chemicals – as toxic substances that

more

Last update: March 06, 2014. 08:41:31 pm.